175 related articles for article (PubMed ID: 37936261)
1. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
[TBL] [Abstract][Full Text] [Related]
2. Serum free light chain analysis: persisting limitations with new kids on the block.
Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Free Immunoglobulin Light Chains in Urine.
Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
[TBL] [Abstract][Full Text] [Related]
5. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
[TBL] [Abstract][Full Text] [Related]
6. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.
Singh G
J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175
[TBL] [Abstract][Full Text] [Related]
7. [Free light chains assay: Indications and methods].
Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
[TBL] [Abstract][Full Text] [Related]
8. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
Morales-García LJ; Pacheco-Delgado MS
Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
[TBL] [Abstract][Full Text] [Related]
10. Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.
Banderker RB; Fazel FB; Zemlin AE; Khine AA; Jalavu TP
Afr J Lab Med; 2023; 12(1):2201. PubMed ID: 38058849
[TBL] [Abstract][Full Text] [Related]
11. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
Lu H; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
[TBL] [Abstract][Full Text] [Related]
13. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
15. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
Lee WS; Singh G
Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines.
Schroeder LF; Manthei DM; Keren DF
Clin Biochem; 2023 Aug; 118():110604. PubMed ID: 37394225
[TBL] [Abstract][Full Text] [Related]
17. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease.
Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ
Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
Lutteri L; Aldenhoff MC; Cavalier E
Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
[TBL] [Abstract][Full Text] [Related]
19. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
Singh G
J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]